معرفی
Professor Mark Molloy is a leading researcher in proteomics and cancer biomarker discovery at the University of Sydney, affiliated with the Faculty of Medicine and Health and Northern Clinical School. Previously, he served as interim Head of the Department of Chemistry and Biomolecular Sciences at Macquarie University until 2017 and directed the Australian Proteome Analysis Facility (APAF) from 2010 to 2018.
- Education: BSc(Hons) from Macquarie University (1995), PhD in proteomics (2000)
- Research Focus: Biomarkers, proteomics, translational research, and molecular mechanisms of colorectal and other cancers
His work leverages mass spectrometry and proteomic technologies to identify prognostic/predictive biomarkers, particularly in bowel cancer, and explores the role of the gut microbiome in cancer development. Recent studies include blood microsampling for cancer detection and microbiome-metabolite interactions.
His 15 most recent publications span topics in colorectal cancer proteomics, Alzheimer's disease biomarkers, microbial biofilms, and precision medicine. Collaborations include institutions in Australia, Germany, and USA.
- Key Associations: Australasian Proteomics Society, American Association for Cancer Research, Human Proteome Organisation
